I don't know much about shorting, but I would think that those who shorted their shares between 4/40 and 5/15 either experienced some pain if they covered since then........OR.....just might experience a whole lot more pain.
Salt, what did you have for breakfast this morning? I would suggest you not eat that again.......it makes what brain you have.....well, dense.
Good to see you are still around, Biowatchdog. Anyway, the original thread was about the Confidential Treatment Order Insmed filed earlier this month. Fud said it "relates to confidential elements of the agreement with Pari". I, in turn, then asked if "he was talking about the CLEAR-108 Phase 3"? There was no clear answer. So, I guess my question was what that was all about?
Levonchiko, could you please clarify something for me? This $18 target price........is it by any chance "pre-split" price?
.....$12.44........UP approximately 9%.........Highest close since June 28, 2011.........1.9 million shares traded today..........most shares traded since June 22, 2012
Welcome NEW investors.
Interesting.....and ACRX is UP 10% so far today. So, that would be sweet if we get another upward movement of 10% tomorrow.....thank you Muttley Fool
With the two instances of raised target prices earlier this morning, is it possible that there are some "early bird" Russell Index buyers to beat the rush in June? I suppose I am jumping the gun a little bit as to the imminence of Insmed being added...
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
TO BE HELD ON MAY 23, 2013
NOTICE IS HEREBY GIVEN that the 2013 Annual Meeting of Shareholders of Insmed Incorporated will be held at the Hilton East
Brunswick Hotel and Executive Meeting Center, 3 Tower Center Boulevard, East Brunswick, New Jersey 08816, on May 23, 2013, at 9:00 a.m.
local time and at any adjournment or postponement thereof, for the following purposes:
1. To elect three Class I directors to serve until the 2016 Annual Meeting of Shareholders;
2. To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending
December 31, 2013;
3. To ratify and approve certain equity compensation awards previously granted to certain current and former employees and
directors under our 2000 Stock Incentive Plan;
4. To approve the Insmed Incorporated 2013 Incentive Plan; and
5. To transact such other business as may properly come before the meeting.
Holders of record of shares of Insmed common stock at the close of business on March 28, 2013, will be entitled to vote at the Annual
You mean a dip lower than $11.33? Of course there is the old saying "never say never" but I can truly say I hope you never see it and I will watch with glee as you perhaps chase it.